MERCIER JOHANNA (Chief Commercial Officer) sold 2.5% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $432.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/16/2026ACC: 0001782135-26-000033
Officer· Chief Commercial Officer
Since Jul 2019
-3K
Net shares
Net seller
$432.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.60K
Price / share
$143.69
Trade value
$229.91K
% of position
1.3%
9/15/2026
119.68K→118.08K
Common Stock
Direct
Shares
−800.00
Price / share
$144.46
Trade value
$115.57K
% of position
0.7%
9/15/2026
118.08K→117.28K
Common Stock
Direct
Shares
−600.00
Price / share
$145.29
Trade value
$87.17K
% of position
0.5%
9/15/2026
117.28K→116.68K
Total
Net shares
−3K
Net value
-$432.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | S · Sale | −1.60K | $143.69 | $229.91K | 1.3% | 119.68K | 118.08K |
| Common Stock Direct | 9/15/2026 | S · Sale | −800.00 | $144.46 | $115.57K | 0.7% | 118.08K | 117.28K |
| Common Stock Direct | 9/15/2026 | S · Sale | −600.00 | $145.29 | $87.17K | 0.5% | 117.28K | 116.68K |
| Total | −3K | -$432.65K | ||||||
Derivative Transactions0
No derivative transactions reported